AWM
NVAX icon

Avior Wealth Management’s Novavax NVAX Stock Holding History

Avior Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17
Closed -$81 – 3215
2024
Q1 		$81 Buy
+17
New +$79 ﹤0.01% 3277
2023
Q3 		– Sell
-25
Closed -$185 – 1652
2023
Q2 		$185 Hold
25
– – ﹤0.01% 1509
2023
Q1 		$173 Hold
25
– – ﹤0.01% 1570
2022
Q4 		$257 Hold
25
– – ﹤0.01% 1206
2022
Q3 		$0 Hold
25
– – ﹤0.01% 1248
2022
Q2 		$1K Hold
25
– – ﹤0.01% 1012
2022
Q1 		$1K Hold
25
– – ﹤0.01% 1048
2021
Q4 		$3K Sell
25
-1,861
-99% -$320K ﹤0.01% 944
2021
Q3 		$390K Buy
1,886
+384
+26% +$84.6K 0.03% 350
2021
Q2 		$318K Buy
1,502
+772
+106% +$141K 0.03% 360
2021
Q1 		$132K Buy
+730
New +$145K 0.01% 435

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avior Wealth Management's NVAX Position: Q2 2024 in Review

Avior Wealth Management sold out of Novavax (NVAX) in Q2 2024, closing a stake of 17 shares — an estimated $81 sold.

Avior Wealth Management first reported a position in NVAX in Q1 2021 and held it in 11 quarters. The position peaked at $390K in Q3 2021. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Avior Wealth Management reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 17 Novavax shares in Q2 2024, an estimated $81.
  • Avior Wealth Management first reported a position in Novavax in Q1 2021 and held it in 11 quarters.
  • Avior Wealth Management's Novavax position peaked at $390K in Q3 2021.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.